Lake forest health and fitness: Novartis' meningitis B vaccine wins breakthrough therapy status in U.S.

Monday, 7 April 2014

Novartis' meningitis B vaccine wins breakthrough therapy status in U.S.

ZURICH (Reuters) - Novartis said U.S. health regulators have granted the Swiss drugmaker's meningitis B vaccine Bexsero breakthrough therapy status.

via Reuters: Health News Read More Here..

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)